Future Market Insights projects that the vutrisiran market will expand at a compound annual growth rate (CAGR) of 12% from 2023 to 2033. It is anticipated that the global market for Vutrisiran would reach a valuation of US$ 2087 million by 2033. Vutrisiran provides patients with hereditary transthyretin-mediated amyloidosis (hATTR) with hope and a new …